CompletedPhase 3NCT01151540
A Long Term Extension Study of E2080 in Lennox-Gastaut Patients
Studying Lennox-Gastaut syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eisai Co., Ltd.
- Principal Investigator
- Hiroki TakanoNeuroscience Clinical Development Section. JAC PCU. Eisai Co., Ltd.
- Intervention
- Rufinamide(drug)
- Enrollment
- 54 enrolled
- Eligibility
- 4-30 years · All sexes
- Timeline
- 2010 – 2013
Study locations (23)
- Nagoya, Aichi-ken, Japan
- Matsuyama, Ehime, Japan
- Fukuoka, Fukuoka, Japan
- Hiroshima, Hiroshima, Japan
- Sapporo, Hokkaido, Japan
- Kobe, Hyōgo, Japan
- Yokohama, Kanagawa, Japan
- Goshi^shi, Kumamoto, Japan
- Iwanuma-shi, Miyagi, Japan
- Ōmura, Nagasaki, Japan
- Nara, Nara, Japan
- Niigata, Niigata, Japan
- Yufu-shi, Oita Prefecture, Japan
- Neyagawa, Osaka, Japan
- Osaka, Osaka, Japan
- +8 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01151540 on ClinicalTrials.govOther trials for Lennox-Gastaut syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06924086The Children's Adaptive Deep Brain Stimulation for Epilepsy TrialUniversity College, London
- RECRUITINGPHASE3NCT05066217An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut SyndromeEpygenix
- RECRUITINGNCT05485831Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALYJazz Pharmaceuticals
- ACTIVE NOT RECRUITINGNANCT06464653Pallidothalamic Tracts Electrical Stimulation for Lennox-Gastaut SyndromeLiankun_Ren
- RECRUITINGNCT05374824Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut SyndromeAnn & Robert H Lurie Children's Hospital of Chicago
- ACTIVE NOT RECRUITINGPHASE4NCT05044819Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral SolutionJazz Pharmaceuticals